Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathieu Molimard

Showing results (21-30 of 170) with videos related to

Pageof 17
Sort By:
Therapie|November 6, 2018
Interest of pharmacoepidemiology for the study of inhaled drugsMathieu Molimard, Pierre-Olivier Girodet, Eric Van Ganse
Therapie|July 10, 2016
[Not Available]Jean-Paul Demarez, Christian Funck-Brentano, Mathieu Molimard, et al.
Therapie|November 1, 2012
[In Process Citation]Jean-Paul Demarez, Christian Funck-Brentano, Mathieu Molimard, et al.
Therapie|November 1, 2012
Conflicts of interests in the area of healthcare products and technology. Current state of affairs and recommendationsJean-Paul Demarez, Christian Funck-Brentano, Mathieu Molimard, et al.
European Journal of Clinical Pharmacology|April 30, 2010
How reimbursement databases can be used to support drug utilisation studies: example using the main French national health insurance system databasePhilippe Latry, Mathieu Molimard, Bernard Bégaud, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery|September 26, 2009
Prevalence and associated factors of oropharyngeal side effects in users of inhaled corticosteroids in a real-life settingMathieu Molimard, Vincent Le Gros, Philip Robinson, et al.
La Revue Du Praticien|October 15, 2020
[Therapeutic education, compliance and self-medication]Pietro Rosellini, Driss Berdaï, Mathieu Molimard, et al.
Respiratory Medicine|May 10, 2005
Total reversibility testing as indicator of the clinical efficacy of formoterol in COPDMathieu Molimard, Jacques Bourcereau, Vincent Le Gros, et al.
European Archives of Psychiatry and Clinical Neuroscience|September 23, 2008
Factors associated with choice of psychotropic drugs used for intentional drug overdoseMarie Tournier, Adeline Grolleau, Audrey Cougnard, et al.
Respiratory Medicine|October 9, 2007
Effectiveness of omalizumab (Xolair) in the first patients treated in real-life practice in FranceMathieu Molimard, Frédéric de Blay, Alain Didier, et al.
Pageof 17

Showing results (21-30 of 170) with videos related to

Sort By:
Pageof 17
Therapie|November 6, 2018
Interest of pharmacoepidemiology for the study of inhaled drugsMathieu Molimard, Pierre-Olivier Girodet, Eric Van Ganse
Therapie|July 10, 2016
[Not Available]Jean-Paul Demarez, Christian Funck-Brentano, Mathieu Molimard, et al.
Therapie|November 1, 2012
[In Process Citation]Jean-Paul Demarez, Christian Funck-Brentano, Mathieu Molimard, et al.
Therapie|November 1, 2012
Conflicts of interests in the area of healthcare products and technology. Current state of affairs and recommendationsJean-Paul Demarez, Christian Funck-Brentano, Mathieu Molimard, et al.
European Journal of Clinical Pharmacology|April 30, 2010
How reimbursement databases can be used to support drug utilisation studies: example using the main French national health insurance system databasePhilippe Latry, Mathieu Molimard, Bernard Bégaud, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery|September 26, 2009
Prevalence and associated factors of oropharyngeal side effects in users of inhaled corticosteroids in a real-life settingMathieu Molimard, Vincent Le Gros, Philip Robinson, et al.
La Revue Du Praticien|October 15, 2020
[Therapeutic education, compliance and self-medication]Pietro Rosellini, Driss Berdaï, Mathieu Molimard, et al.
Respiratory Medicine|May 10, 2005
Total reversibility testing as indicator of the clinical efficacy of formoterol in COPDMathieu Molimard, Jacques Bourcereau, Vincent Le Gros, et al.
European Archives of Psychiatry and Clinical Neuroscience|September 23, 2008
Factors associated with choice of psychotropic drugs used for intentional drug overdoseMarie Tournier, Adeline Grolleau, Audrey Cougnard, et al.
Respiratory Medicine|October 9, 2007
Effectiveness of omalizumab (Xolair) in the first patients treated in real-life practice in FranceMathieu Molimard, Frédéric de Blay, Alain Didier, et al.
Pageof 17